Cheng, Hao-Yuan <br/><br/>
Studying the enhancement of programmed cell death by combined AG1024 and paclitaxel in a model of chronic myelogenous leukemia.  [electronic resource] 

 -  Life sciences  May 2014 
 - 118-26 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0631 
<br/><br/><label>Standard No.: </label>10.1016/j.lfs.2014.03.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Apoptosis--drug effects<br/>Drug Delivery Systems--methods<br/>Drug Therapy, Combination<br/>Humans<br/>K562 Cells<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Paclitaxel--administration & dosage<br/>Tyrphostins--administration & dosage<br/>Up-Regulation--drug effects